311 related articles for article (PubMed ID: 26252008)
1. Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.
Xie C; Tang Y; Wang Y; Yu T; Wang Y; Jiang L; Lin L
PLoS One; 2015; 10(8):e0127815. PubMed ID: 26252008
[TBL] [Abstract][Full Text] [Related]
2. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
Ruepert L; Quartero AO; de Wit NJ; van der Heijden GJ; Rubin G; Muris JW
Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD003460. PubMed ID: 21833945
[TBL] [Abstract][Full Text] [Related]
3. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for irritable bowel syndrome-A systematic review.
Kułak-Bejda A; Bejda G; Waszkiewicz N
Pharmacol Rep; 2017 Dec; 69(6):1366-1379. PubMed ID: 29132094
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
6. Antidepressants versus placebo for panic disorder in adults.
Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
[TBL] [Abstract][Full Text] [Related]
7. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis.
Häuser W; Wolfe F; Tölle T; Uçeyler N; Sommer C
CNS Drugs; 2012 Apr; 26(4):297-307. PubMed ID: 22452526
[TBL] [Abstract][Full Text] [Related]
8. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
9. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
Black CJ; Yuan Y; Selinger CP; Camilleri M; Quigley EMM; Moayyedi P; Ford AC
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):117-131. PubMed ID: 31859183
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants for insomnia in adults.
Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis.
Ford AC; Talley NJ; Schoenfeld PS; Quigley EM; Moayyedi P
Gut; 2009 Mar; 58(3):367-78. PubMed ID: 19001059
[TBL] [Abstract][Full Text] [Related]
13. Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.
Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
Am J Gastroenterol; 2014 Sep; 109(9):1350-65; quiz 1366. PubMed ID: 24935275
[TBL] [Abstract][Full Text] [Related]
14. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants for agitation and psychosis in dementia.
Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
Zheng Y; Yu T; Tang Y; Xiong W; Shen X; Jiang L; Lin L
PLoS One; 2017; 12(3):e0172846. PubMed ID: 28291778
[TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
20. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]